Research Panel

Stock Quotes for Research Panel top ^
  • Industry: Lumber & Wood Production
  • Sector: Basic Materials
  • Stock Style: Small Value
Sign-up for 526490 investment picks

News Articles for Research Panel top ^
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of a new highly multiplexed gene expression panel for the nCounter ® Analysis System, the PanCancer Immune Profiling Panel.
Sign-up for NanoString Introduces Novel Gene Expression Panel for Immuno-Oncology Research investment picks
Comprehensive Clinical Data from Randomized Trials Reviewed MARLBOROUGH, Mass.
Sign-up for FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device investment picks
Ixia (Nasdaq: XXIA) announced today that a NASDAQ Hearings Panel (the “Panel”) has determined to extend the date by which the company must become current in filing its required periodic financial reports with the Securities and Exchange Commission (the “SEC”) from September 12, 2014 to November 13, 2014.
Sign-up for NASDAQ Hearings Panel Extends Date for Ixia to Become Current in its SEC Filings investment picks
GERMANTOWN, Maryland and HILDEN, Germany , July 15, 2014 /PRNewswire/ -- QIAGEN introduces 14 new panels for targeted enrichment of up to 570 clinically-relevant genes, expands largest portfolio of panels for assessing cancer genes GeneRead DNAseq V2 gene panels integrate with QIAGEN bioinformatics, allowing customization of assays and streamlined data analysis and interpretation for fast generation of valuable insights Launches support QIAGEN's strategy to deliver significant NGS workflow improvements in speed and cost through high-quality 'universal' solutions compatible with any sequencer QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of 14 new GeneRead TM DNAseq V2 gene panels targeting an extensive range of cancer-related genes or gene regions.
Sign-up for QIAGEN Advances Leadership in Pre-Analytical Solutions for Next-generation Sequencing (NGS) With Launch of 14 New Cancer Gene Panels investment picks
Responds to Gastroenterology and Urology Devices Panel Vote on Ablatherm-HIFU for Treatment of Prostate Cancer LYON, France, Aug.
Sign-up for EDAP Comments on FDA Panel Vote investment picks
On Tuesday, September 16, Teresa Madden, Sr Vice President and CFO at Xcel Energy (NYSE:XEL) will participate in panel presentations at the Bank of America Merrill Lynch Power and Gas Leaders Conference in Boston as follows: Interested investors can access the live audio webcast of the panel and presentation materials at: Click on: Investors For more information, contact: Paul Johnson, Vice President, Investor Relations 612-215-4535 News media inquiries call Xcel Energy media relations 612-215-5300 Xcel Energy Internet address: This information is not given in connection with any sale or offer for sale or offer to buy any security.
Sign-up for Xcel Energy to Participate in Panel Presentations at Bank of America Merrill Lynch Conference investment picks
Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML , the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated genes found in acute myeloid leukemia.
Sign-up for Agilent Technologies Introduces Next-Generation Sequencing Cancer Research Panels investment picks
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Ikea will expand the sale of solar-panel systems to eight countries after nearly a year of selling them in the U.K. The Swedish home-furnishings company said Monday it will roll out the new products in the Netherlands next month, and in Switzerland later this year.
Sign-up for Solar panels may be coming to an Ikea near you investment picks
This comprehensive syndromic panel tests for greater than 90% of bacterial, viral, and parasitic causes of infectious gastroenteritis in a single molecular test AUSTIN, Texas , Sept.
Sign-up for Luminex Receives FDA Clearance To Add New Clinical Targets And Additional Sample Type For Use With xTAG® Gastrointestinal Pathogen Panel investment picks
First and Only Solar Company to Achieve this Recognition for its Products SAN JOSE, Calif.
Sign-up for SunPower Solar Panels Awarded Cradle to Cradle Certification for Sustainable Manufacturing Processes investment picks
TPG Specialty Lending, Inc. (NYSE:TSLX, “the Company") announced today that Joshua Easterly, the Company's Co-Chief Executive Officer and Chairman of the Board, is scheduled to participate in the BDC Panel discussion at the 2014 Barclays Global Financial Services Conference today at 3:30 p.m. at the New York Hilton Midtown, 1335 Avenue of the Americas, New York City.
Sign-up for TPG Specialty Lending, Inc. Co-CEO Joshua Easterly to Participate in BDC Panel at Barclays Global Financial Services Conference investment picks
Live Panel And Conference Call Scheduled for 7:30 a.m. CDT on September 15, 2014 Data Presented During Poster Session at ASBMR 2014 WALTHAM, Mass., Sept.
Sign-up for Radius Health to Host Scientific Panel Discussion for Investors on Investigational Drug Abaloparatide at ASBMR 2014 investment picks
2014/7/28 DENVER, CO--(Marketwired - July 28, 2014) - Novagant, Inc. (PINKSHEETS: NVGT) is pleased to announce that it will present its AlKanna LED grow lights, its GLAVape™ medical cannabis vaporizer product, and its GoldenCBD™ Cannabidiol products at the 2014 Money Show in San Francisco, and will be a speaker on the Cannabis Panel at the Money Show.
Sign-up for Novagant, Inc. Will Exhibit Its Cannabidiol Product Lines at the 2014 Money Show and Speak on the Cannabis Panel at the Money Show investment picks
By Bill Sanderson Rising energy prices and falling costs for electricity-generating solar panels make rooftop solar installations a good way for millions of American homeowners to slash their electric bills.
Sign-up for UPDATE: Want to go solar? Buy the panels investment picks
Rambus Inc. (NASDAQ:RMBS): Who: Rambus Cryptography Research Division (NASDAQ:RMBS) Benjamin Jun, vice president and chief technology officer of the Rambus Cryptography Research division, will participate in the MobileCON cybersecurity panel during Super Mobility Week.
Sign-up for Rambus Cryptography Research Division to Speak on MobileCON Cybersecurity Panel at Super Mobility Week investment picks
General Growth Properties, Inc. (the "Company") (NYSE: GGP) today announced Sandeep Mathrani, chief executive officer, will participate in a panel discussion titled “Omnichannel & The Future of Retail” at the Bank of America 2014 Global Real Estate Conference in New York on Thursday, September 11, 2014 at 1:20 p.m. Eastern Time.
Sign-up for General Growth Properties to Participate in Panel Discussion at Bank of America 2014 Global Real Estate Conference investment picks
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- A second-quarter miss for Yingli Green Holding on Wednesday was a fitting end to an earnings season that most Chinese solar-panel makers would probably like to forget.
Sign-up for Chinese solar-panel makers place hopes on second half investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.


Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Panel
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Output  |  Next: Research Paper